Preoperative risk factors for febrile UTI after ureteroscopy

Ureteroscopy is a common way to remove stones from the ureter or kidney. During the procedure, instruments pass through the urinary tract, potentially releasing bacteria and inflammatory material. The result may be fever, including a febrile urinary tract infection that requires further assessment and treatment.

Preoperative risk assessment helps identify who needs closer follow-up, a urine culture, targeted prophylaxis or a documented escalation plan. It should combine previous cultures, urinary symptoms, medical conditions and anatomy rather than rely on one laboratory result or a single demographic label.

Fever after ureteroscopy is not automatically a UTI. Some episodes reflect sterile inflammation; others accompany bacteraemia or a true infection. Temperature, symptoms, urine findings, imaging and the patient’s condition must be interpreted together, with urgent review when deterioration is possible.

Australian planning adds practical questions: Will care occur through Medicare-funded public services or a private hospital? Can a local GP review results and prescribe medicines? What happens after hours in a regional area? Clear answers matter where transfer is rapid in major cities and where remote communities may wait longer for review.

Why ureteroscopy can trigger fever

Ureteroscopy creates several routes for infection. Instrumentation can carry uropathogens from the urethra into the upper tract, while manipulation of an infected or obstructed system may release bacteria and endotoxins. A ureteral stent, urinary drainage device or pre-existing infection can add to the risk, so the timing of symptoms matters.

Not every postoperative fever has the same cause. Other urological symptoms should not be folded into an infection pathway without assessment; for example, the journal’s review of Peyronie disease treatments shows how a separate condition requires its own diagnosis, prevention and consent process. Fever, urinary pain and abnormal imaging should still be assessed together.

Identifying infection before surgery

A urine culture obtained before instrumentation is central to risk assessment. A result showing significant growth needs review for asymptomatic bacteriuria, contamination or symptomatic infection, with treatment considered under local urology and antibiotic guidance. Recording the organism and susceptibility pattern helps if fever develops later.

Previous urinary infections, recent hospital antibiotics, urinary retention and symptoms such as frequency, dysuria or loin pain increase the chance that infection is already present. Ask whether previous cultures were treated and whether symptoms resolved; a single negative culture does not exclude infection if symptoms persist or antibiotics were recently used.

Patients who want background reading can consult broader patient health information, but it should not be used to decide whether a current result needs treatment. The responsible clinician should interpret symptoms, cultures and imaging together and arrange review when the clinical picture changes.

Patient factors that raise risk

Several patient factors are associated with febrile UTI after ureteroscopy: recurrent UTI, diabetes, obesity, impaired renal function, immunosuppression and, in some cohorts, female sex or older age. These are population-level associations, not reasons to deny treatment or predict an individual’s outcome.

Diabetes control deserves particular attention because hyperglycaemia can blunt symptoms and impair host defence. Review recent HbA1c, renal function, medicines and any complications of diabetes. Correct relevant abnormalities before elective surgery when feasible, while not delaying urgent drainage of an obstructed infected system.

Equity also affects prevention and follow-up. In Aboriginal and Torres Strait Islander communities, partnership with local Aboriginal health teams and community-controlled services can support culturally safe care, shared decisions and reliable contact arrangements. This is especially important where distance, housing instability or transport barriers can delay assessment.

Stone burden and urinary anatomy

Stone size, impaction, hydronephrosis and obstruction often reflect a more complex urinary tract. Preoperative imaging should establish whether drainage is needed and whether infection is present. A planned ureteric stent is not a substitute for treating bacteria, and a patient with a stent already in place needs a culture interpreted in that context.

Where infection and obstruction coexist, definitive stone treatment may need to be staged. Antibiotics and drainage are prioritised, with definitive ureteroscopy once the patient is stable and the infection is controlled. For people living outside major cities, including remote parts of northern Australia, this extra stage should be planned with local hospital and transport services rather than assumed to fit a single appointment.

Choosing cultures and antibiotics wisely

Antibiotic choice should be guided by the pre-procedure culture, allergy history, renal function and local resistance data. Australian prescribers can use national guidance such as Therapeutic Guidelines: Antibiotics alongside hospital antibiograms, which show local patterns that national summaries may miss. Prophylaxis is aimed at the procedure, while an established infection requires a treatment regimen and review.

Timing matters: doses should be given according to the relevant protocol and procedure, with any delay or postoperative infection handled promptly. Avoid carrying an old antibiotic forward without checking the current organism and sensitivities. If a patient was already taking an antibiotic, document why and when it stopped, because a later culture may be misleading.

Costs should not obscure prevention. Medicare subsidises many pathology services and public outpatient care, while eligible prescriptions are subsidised through the PBS; private treatment may involve a private insurer and patient fees. A clinician or GP can check current coverage and avoid delaying a culture, review or essential antibiotic.

Building a preoperative risk assessment

A practical preoperative review should confirm whether a current culture is available, list prior urinary infections and antibiotic use, document urinary symptoms and recent hospital stays, assess diabetes and immunosuppression, and record hydronephrosis, obstruction or a stent. The urologist can then decide whether antibiotics, closer follow-up or alternative staging is appropriate.

For men, the record should also include prostate symptoms and anticoagulant use, without treating PSA as a marker of infection. The debate summarised in PSA screening controversies reinforces why incidental findings need context-specific interpretation rather than automatic additional testing.

Discharge planning starts before admission. Record the surgeon’s contact, a local GP or urgent-care option, the number for 000 and when hospital review is required. Patients in Melbourne, Sydney or Brisbane can generally choose between public and private pathways, but affordability, insurer rules and waiting times differ. Telehealth can support review in regional areas, although fever and sepsis require physical assessment.

When fever appears after discharge

After discharge, a temperature of 38°C or higher, rigors, flank or back pain, nausea, vomiting or feeling generally unwell warrants prompt contact with the urologist or GP. Recurrent rigors and persistent fever deserve same-day review. The original operative note and culture results should be available to the assessing clinician.

Call 000 for confusion, collapse, difficulty breathing, a very fast heart rate, markedly low blood pressure, reduced urine output or other signs of sepsis. These symptoms are not managed by waiting for an appointment. Healthdirect on 1800 022 222 can provide nursing advice when 000 is not required, and hospital admissions teams can clarify which nearby emergency pathway is covered.

Persistent haematuria, unexplained weight loss or other cancer warning signs should not be relabelled as a routine postoperative infection. Investigation may reveal a different problem, and treatment pathways can diverge completely; the journal’s overview of metastatic urothelial immunotherapy illustrates the specialist decisions involved once urothelial malignancy is confirmed.

Before ureteroscopy, ask your urologist to document a recent urine culture, review previous urinary infections and antibiotic records, assess diabetes and immunosuppression, and record urinary anatomy. Leave with written instructions covering whom to call during business hours, where to attend after hours and which symptoms require 000.

If fever develops after the procedure, contact your urologist or GP the same day when feasible; call 000 for confusion, collapse, breathing difficulty, severe weakness or reduced urine output. Keep the contact details and escalation plan accessible so infection can be recognised and treated without delay.